Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ralf, Birkemeyer"'
Autor:
Stefan Weber, Clemens Winterhalder, Christina J. Raichle, Noé Brasier, Marcus Dörr, Thilo Burkard, Licia Leonardi, Jens Eckstein, Ralf Birkemeyer
Publikováno v:
American heart journal. 233
Background The possibility to use built-in smartphone-cameras for photoplethysmographic (PPG) recording of pulse waves lead to the release of numerous health apps, claiming to measure blood pressure (BP) based on PPG signals. Even though these apps a
Autor:
Bernward Lauer, Oana Brosteanu, Petra Neuhaus, Marcus Wiemer, Roland Prondzinsky, Christoph Axthelm, Rüdiger C. Braun-Dullaeus, Jochen Wöhrle, Rainer Zimmermann, Helmut Schuehlen, Harald Rittger, Rainer Hambrecht, Klaus Kleinertz, Sebastian Kerber, Ralf Birkemeyer, Martin Bergmann, Wolfgang Burckhardt, Markus Ferrari, Peter Sick, Holger Thiele, Gerhard Schuler
Publikováno v:
American heart journal. 159(4)
Background Intravenous abciximab reduces major adverse cardiac events in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Intracoronary abciximab bolus application during PCI result
Autor:
Dariusz Dudek, Jacek S. Dubiel, Waldemar Mielecki, Jacek Legutko, Magnus Janzon, Krzysztof Zmudka, Justyna Stefaniak, Rafał Depukat, Ralf Birkemeyer, Lukasz Partyka, Tomasz Rakowski, Zbigniew Siudak, Artur Dziewierz
Publikováno v:
American heart journal. 158(4)
Background There are conflicting data on the clinical benefit from early administration of abciximab from a large randomized trial and a registry. However, both sources suggest that a benefit may depend on the baseline risk profile of the patients. W
Autor:
Dariusz, Dudek, Zbigniew, Siudak, Magnus, Janzon, Ralf, Birkemeyer, Guillermo, Aldama-Lopez, Corrado, Lettieri, Bogdan, Janus, Andrzej, Wisniewski, Sergio, Berti, Zoran, Olivari, Tomasz, Rakowski, Lukasz, Partyka, Jochen, Goedicke, Krzysztof, Zmudka, Ramiro, Trillo Nouche
Publikováno v:
American heart journal. 156(6)
Abciximab is established as adjunct to primary percutaneous coronary intervention (PCI). Based on some smaller studies, ST-segment elevation myocardial infarction (STEMI) networks in various European countries have adopted the start of abciximab befo